NYHA class

Biomarker1 paper

Latest

10

Cardiovascular ResearchReview8 h

Growth hormone and aging cardiomyocytes

Journal of Personalized MedicineHumans24 Sep

Exploratory Biomarker-Defined Phenotypic Heterogeneity Beyond a Single Physiological Reserve Construct

GeriatricsHumans23 Sep

Long-Term Survival of Very Elderly Patients with Heart Failure Managed in a Comprehensive Heart Failure Management Unit

Cardiology and TherapyHumans13 Sep

Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy

International Journal of CardiologyHumans8 Sep

Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study

Clinical CardiologyHumans6 Sep

Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results

Frontiers in Cardiovascular MedicineHumans4 Sep

Safety & efficacy of sodium glucose co-transport 2 (SGLT2) inhibitors in elderly patients with heart failure

SGLT2 inhibitors

ESC Heart FailureHumans1 Sep

Dapagliflozin effects on right ventricular function, pulmonary pressure and coupling: a propensity score analysis from the RIVED-HF

Preprints.orgHumansPreprint27 Aug

Biomarker-Defined Phenotyping Reveals Patient Heterogeneity Not Captured by a Single Physiological Reserve Score

AHA Scientific Sessions 2025 AbstractHumans3 Nov

In-Hospital, 1-Year and 5-Year Clinical Outcomes of Patients With Severe Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement and Sodium-Glucose Cotransporter 2 Inhibitors